首页> 外文OA文献 >Novel synthesis of O6-alkylguanine containing oligodeoxyribonucleotides as substrates for the human DNA repair protein, O6-methylguanine DNA methyltransferase (MGMT)
【2h】

Novel synthesis of O6-alkylguanine containing oligodeoxyribonucleotides as substrates for the human DNA repair protein, O6-methylguanine DNA methyltransferase (MGMT)

机译:新型合成的O6-烷基鸟嘌呤含有寡脱氧核糖核苷酸作为人类DNA修复蛋白O6-甲基鸟嘌呤DNA甲基转移酶(MGMT)的底物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The human DNA repair protein O6-methylguanine DNA methyltransferase (MGMT) dealkylates mutagenic O6-alkylguanine lesions within DNA in an irreversible reaction which results in inactivation of the protein. MGMT also provides resistance of tumours to alkylating agents used in cancer chemotherapy and its inactivation is therefore of particular clinical importance. We describe a post-DNA synthesis strategy which exploits the novel, modified base 2-amino-6-methylsulfonylpurine and allows access for the first time to a wide variety of oligodeoxyribonucleotides (ODNs) containing O6-alkylguanines. One such ODN containing O6-(4-bromothenyl)guanine is the most potent inactivator described to date with an IC50 of 0.1 nM.
机译:人类DNA修复蛋白O6-甲基鸟嘌呤DNA甲基转移酶(MGMT)在不可逆反应中使DNA内的诱变O6-烷基鸟嘌呤损伤脱烷基,导致该蛋白失活。 MGMT还使肿瘤对用于癌症化学疗法的烷基化剂具有抗性,因此其灭活具有特殊的临床重要性。我们描述了一种后DNA合成策略,该策略利用了新颖的,经过修饰的碱2-氨基-6-甲基磺酰基嘌呤,并首次允许首次访问包含O6-烷基鸟嘌呤的多种寡脱氧核糖核苷酸(ODN)。一种迄今为止包含O6-(4-溴噻吩基)鸟嘌呤的ODN是迄今为止描述的最有效的灭活剂,IC50为0.1 nM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号